Humana (HUM) Capital Expenditures (2009 - 2026)

Humana (HUM) has 18 years of Capital Expenditures data on file, last reported at $121.0 million in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 27.37% year-over-year to $121.0 million in Q1 2026; TTM through Mar 2026 was $572.0 million, a 16.02% increase from a year earlier, with the FY2025 full-year figure at $546.0 million, down 5.04% from the prior year.
• Capital Expenditures for Q1 2026 stood at $121.0 million, down from $202.0 million in the prior quarter.
• Over the last five years, Capital Expenditures for HUM reached as high as $295.0 million in Q1 2022 and fell as low as $95.0 million in Q1 2025.
• Historically, Capital Expenditures has averaged $199.0 million across 5 years, with a median of $202.0 million in 2025.
• Across the five-year window, Capital Expenditures plunged 56.82% in 2024 and jumped 31.17% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $275.0 million in 2022, then climbed by 2.91% to $283.0 million in 2023, then tumbled by 45.58% to $154.0 million in 2024, then surged by 31.17% to $202.0 million in 2025, then plunged by 40.1% to $121.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $121.0 million in Q1 2026, $202.0 million in Q4 2025, and $135.0 million in Q3 2025.